Adam Monroe

Adam Monroe is the Chief Executive Officer of Panaceutics.

Monroe brings more than 25 years of experience with industrial biotechnology, including the food, beverage and nutrition industry, to the role. He previously served as President-Americas for Novozymes, a global biobased solutions company. There he led the Americas leadership team who collectively managed the Sales, Supply and Development of a $900 million enzyme and microbials business in more than 30 markets across North and South America. Monroe also led Novozymes Global Sustainability and Public Affairs efforts utilizing an award-winning model with policy impact to the global business from Brussels to Brasilia, Beijing and Washington, D.C. He has been a leading national voice for nature's solutions and their sustainable impact on business and society.